术者手术量对病态肥胖患者初次全膝关节置换术后结局的影响:基于美国关节置换登记系统的分析
本研究利用美国关节置换登记系统(AJRR)分析2017至2021年间4,829名术者完成的833,099例初次全膝关节置换术(TKA),评估术者TKA总量及肥胖特异性TKA量对病态肥胖患者翻修风险的影响。结果显示,术者年TKA总量中位数为85例,肥胖特异性TKA量中位数为11例;术者手术量(总体或肥胖特异性)与病态肥胖患者任何翻修或假体周围感染(PJI)翻修风险均无显著关联(P > 0.05)。结论认为,术者手术量似乎不是病态肥胖患者初次TKA结局优化的可调节风险因素。
要点
- 术者年TKA总量中位数为85例,肥胖特异性TKA量中位数为11例。
- 术者TKA总量与病态肥胖患者任何翻修或PJI翻修风险均无显著关联(P > 0.05)。
- 术者肥胖特异性TKA量与病态肥胖患者任何翻修或PJI翻修风险均无显著关联(P > 0.05)。
核心结论
- 病态肥胖患者由低手术量或高手术量术者行初次TKA后,任何翻修和PJI翻修的风险相似。
- 术者年肥胖特异性初次TKA量与上述终点在该患者人群中无关联。
- 基于这些数据,术者手术量似乎不是病态肥胖患者初次TKA结局优化的可调节风险因素。
研究设计与样本
- 利用美国关节置换登记系统(AJRR)识别2017年至2021年间4,829名术者完成的833,099例初次TKA。
- 术者初次TKA总量(包括所有患者、所有体重指数的初次TKA)和肥胖特异性初次TKA量(仅包括体重指数≥40患者的初次TKA)基于每名术者每年完成的初次TKA中位数计算。
- 采用多因素逻辑回归评估术者手术量和肥胖特异性手术量对任何原因翻修和假体周围感染(PJI)翻修风险的影响。
- 证据等级为IV级。
主要发现
- 术者TKA总量中位数为85例/年(范围1至466),术者肥胖特异性TKA量中位数为11例/年(范围1至242)。
- 术者TKA总量增加与病态肥胖患者任何翻修风险降低或PJI翻修风险降低均无关联(所有P > 0.05)。
- 术者肥胖特异性初次TKA量与病态肥胖患者TKA后任何翻修风险或PJI翻修风险之间均无关联(所有P > 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to utilize the American Joint Replacement Registry (AJRR) to examine the effects of surgeon total knee arthroplasty (TKA) volume and surgeon obesity-specific TKA volume on rates of revision following primary TKA in patients who have morbid obesity. METHODS: We identified 833,099 primary TKAs performed from 2017 to 2021 by 4,829 surgeons in the American Joint Replacement Registry. Surgeon primary TKA volumes (includes primary TKAs in all patients, all body mass indices [BMIs]) and obesity-specific primary TKA volumes (includes only primary TKAs in patients who have a body mass index (BMI) ≥ 40) were calculated based on the median annual number of primary TKAs performed per surgeon. Multivariate logistic regression was used to evaluate the effects of surgeon volume and obesity-specific volume on the risk of all-cause revision and revision for periprosthetic joint infection (PJI). RESULTS: Median surgeon TKA volume was 85 cases/year (range, one to 466), and median surgeon obesity-specific TKA volume was 11 cases/year (range, one to 242). Increasing surgeon TKA volume was not associated with a decreased risk of any revision or a decreased risk of revision for PJI (P > 0.05 for all) for patients who had morbid obesity. Similarly, there were no associations between surgeon obesity-specific primary TKA volume and risk of any revision or revision for PJI following TKA in patients who had morbid obesity (P > 0.05 for all). CONCLUSIONS: Morbidly obese patients had a similar risk of any revision and PJI after undergoing primary TKA performed by low-volume or high-volume surgeons. Similarly, the surgeon's annual obesity-specific primary TKA volume was not associated with these endpoints in this patient population. Based on these data, surgeon volume does not appear to be a modifiable risk factor for optimization of outcomes in morbidly obese patients undergoing primary TKA. LEVEL OF EVIDENCE: IV.
引用
- Carender CN, Jimenez E, De A, et al. Effects of Surgeon Volume on Outcomes Following Primary Total Knee Arthroplasty in the Morbidly Obese: An Analysis From the American Joint Replacement Registry. J Arthroplasty. 2025. PMID: 40373831. doi:10.1016/j.arth.2025.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。